Additionally, these medications enhance insulin secretion in a glucose-dependent manner and suppress glucagon release, contributing to improved glycemic control in patients with type 2 diabetes
Weight reduction: loose up to 15-20% of body weight
Their pleiotropic benefits arise from intricate signalling cascades that regulate appetite, insulin secretion, and energy homeostasis across multiple tissues
This is a popular strategy for those who find the initial 1224 hours post- injection to be the most challenging
Unplanned pregnancies in women treated with GLP-1 agonists for obesity
Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G Jr., et al